A Quality of Life Study in Patients With Migraines
NCT00298805 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2013-08-12
Summary
The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.
Conditions
Sponsors & Collaborators
-
Rush University Medical Center
collaborator OTHER - collaborator INDUSTRY
-
Northwell Health
lead OTHER
Principal Investigators
-
Andres M Kanner, MD · Rush University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2009-06-30
- Completion
- 2013-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
NCT02991430 ·Status: TERMINATED ·Phase: NA
-
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
NCT00253175 ·Status: COMPLETED ·Phase: PHASE3
-
MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
NCT00797667 ·Status: TERMINATED ·Phase: PHASE2
-
Study in Participants With Acute Migraines Headaches
NCT00804973 ·Status: TERMINATED ·Phase: PHASE2
-
Migraine Prophylaxis With Clopidogrel Trial
NCT02938182 ·Status: UNKNOWN ·Phase: PHASE4
-
Cabergoline for Episodic Migraine
NCT07072910 ·Status: RECRUITING ·Phase: PHASE2
-
One-Day Intervention for Depression and Impairment in Migraine Patients
NCT02108678 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine
NCT04069897 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
NCT00246337 ·Status: COMPLETED ·Phase: PHASE2
-
Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
NCT07061847 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
NCT02959190 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Factors Underlying the Discontinuation of Triptans
NCT00890357 ·Status: COMPLETED
-
Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277 ·Status: TERMINATED
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
NCT00360282 ·Status: COMPLETED ·Phase: NA
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
A Study in Migraine Prevention
NCT01184508 ·Status: TERMINATED ·Phase: PHASE2
-
Chordate System S020 Acute Migraine Clinical Investigation
NCT02185703 ·Status: TERMINATED ·Phase: NA
-
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
NCT04271202 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
NCT02959177 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
NCT01617941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study on Migraine and Headache in Epileptic Patients
NCT00642564 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
NCT00231595 ·Status: COMPLETED ·Phase: PHASE3